ABL Bio298380 
$19.514.79%24h
4.79%24h
Global rank8087
Market cap$934.29M
Change 7d-6.72%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
ABL Bio (298380) Stock Overview
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam, South Korea.
298380 Stock Information
Symbol
298380Address
16 Daewangpangyo-Ro 712 Beon-GilSeongnam-si, 13488South Korea
Founded
-Trading hours
-Website
https://www.ablbio.comCountry
🇰🇷 South KoreaPhone Number
82 31 8018 9800ABL Bio (298380) Price Chart
-
Value:-
ABL Bio Overview: Key Details and Summary
Stock data | 2025 | Change |
|---|---|---|
| Price | $19.51 | N/A |
| Market Cap | $934.29M | N/A |
| Shares Outstanding | 47.89M | N/A |
| Employees | 0 | N/A |
